Pharmacology Discovery Services is a drug discovery CRO with over 30 years of experience in conducting non-GLP in vivo safety and efficacy studies to evaluate the pharmacological effects of drug candidates. We provide flexible services with therapeutically focused disease models that incorporate biomarkers and outcome measures to enable greater prediction of success in the clinic. Pharmacology Discovery Services is a partner lab of Eurofins Discovery.
The Pharmacology Discovery Services facility is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). We also have Office of Laboratory Animal Welfare (OLAW) assurance approval and we are compliant with International Guiding Principles for Biomedical Research (CIOMS), U.S. FDA, European EMEA & Japanese MHW, and Office of Laboratory Welfare (OLAW).
Each of our Technical Directors specializes in selected therapeutic areas so they may provide expert scientific support to our clients. This involves consulting with clients to identify an appropriate model to meet their scientific objectives, designing studies and writing statements of work. Our laboratory staff has worked with numerous types of test agents and they have experience with a broad range of formulation and dosing options.
CNS / Pain
Inflammation / Allergy
Metabolic / Endocrine